Is it acceptable for people to take methylphenidate to enhance performance? No
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b1956 (Published 18 June 2009) Cite this as: BMJ 2009;338:b1956
- Anjan Chatterjee, professor
- 1Department of Neurology and Center for Cognitive Neuroscience, University of Pennsylvania, 3 West Gates, 3400 Spruce Street, Philadelphia PA 19104, USA
- anjan{at}mail.med.upenn.edu
Why would anyone object to someone choosing to be smarter, better focused, and more productive? Surely cognitive enhancement has much to offer individuals and society, and legal dispensers of methylphenidate (Ritalin) should not object. Unfortunately, the case for healthy people taking this drug is not so straightforward. Doctors routinely decide whether to intervene based on a calculation of relative risks and benefits. Here, the risks outweigh the benefits.
Some doctors might reflexively think that the answer to the target question is an obvious “no.” After all, doctors are in the business of treating disease and not enhancing normal abilities. On scrutiny, this distinction proves to be unreliable, particularly when conditions lack clear categorical boundaries. For example, if individuals of short stature can be “treated” with growth hormone,1 …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.